UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of
Report (Date
of
earliest event reported):
June 30, 2005
RITA
Medical Systems, Inc.
(Exact
name of registrant as specified in its charter)
000-30959
(Commission
File Number)
California
|
94-3199149
|
(State
or other jurisdiction of incorporation)
|
(I.R.S.
Employer Identification No.)
|
|
|
46421
Landing Parkway
Fremont,
CA 94538
(Address
of principal executive offices, with zip code)
(510)
771-0400
(Registrant's
telephone number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
o |
Written
communications pursuant to Rule 425 under the Securities Act
(17 CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR
240.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR
240.13e-4(c))
|
Item
4.01 Changes
in Registrant's Certifying Accountant.
As
previously disclosed by RITA Medical Systems, Inc. (the "Company") on a Current
Report on Form 8-K filed on May 27, 2005, the Company received notice from
PricewaterhouseCoopers LLP ("PwC") that PwC was resigning as the Company's
independent registered public accounting firm effective May 23,
2005.
On
June
30, 2005, the Audit Committee of the Company's Board of Directors engaged
Stonefield Josephson, Inc. as the Company's independent registered public
accounting firm to audit the Company's financial statements for the year
ending
December 31, 2005.
During
the years ended December 31, 2004 and December 31, 2003 and through June
30,
2005, the effective date of the engagement of Stonefield Josephson, Inc.
as the
Company's independent registered public accounting firm, neither the Company
nor
anyone on its behalf has consulted Stonefield Josephson, Inc. with respect
to
the application of accounting principles to a specified transaction either
completed or proposed, the type of audit opinion that might be rendered on
the
Company's financial statements, or any matter that was either (i) the subject
of
a disagreement as defined in Item 304(a)(1)(iv) of Regulation S-K promulgated
by
the Securities and Exchange Commission (the "SEC") or (ii) a "reportable
event"
as defined in Item 304(a)(1)(v) of Regulation S-K promulgated by the
SEC.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date:
July 5, 2005
RITA
MEDICAL SYSTEMS, INC.
By:
/s/Joseph
DeVivo
Joseph
DeVivo
President
and Chief Executive Officer